Skip to main content
OpenTrials

Clinical trial condition

Endometrial Carcinoma

Explore clinical trials studying Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.

79 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Carcinoma trial results

Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

NCT03372720

Conditions
Adnexal Diseases, Cervical Carcinoma, Dyspareunia, +33 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Sanford Roger Maris Cancer Center Fargo, North Dakota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

NCT02807844

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +31 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The West Clinic Germantown, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 20 locations
View Trial Details

Related conditions